- Mary J Laughlin, Division of Hematology/Oncology, University of Virginia
- Dan L Longo, National Institute on Aging, National Institutes of Health
- Peter O'Donovan, BioMed Central
News from the web
- 11 December 2013
- Studies uncover new insights into pathophysiology of sickle cell disease and thalassemia, may help improve standard of care
- 11 December 2013
- FoundationOne™ Heme enables identification of genomic alterations not identified by conventional methods across hematologic malignancies
- 10 December 2013
- Scientists recommend testing for Pearson syndrome in patients with congenital anemia
BMC Hematology is an open access, peer-reviewed journal that considers articles on basic, experimental and clinical research related to hematology. The journal welcomes submissions on non-malignant and malignant hematological diseases, hemostasis and thrombosis, hematopoiesis, stem cells and transplantation.
It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.
Join the Editorial Board!
Are you interested in becoming an Editorial Board member for BMC Hematology and helping to maintain the editorial standards and ethos of this growing journal? To volunteer as an Associate Editor, please simply contact us at email@example.com, enclosing a summary of your research interests and relevant expertise. We look forward to hearing from you.
Section Editor's profile
Dan L. Longo
Dr. Longo is Professor of Medicine at Harvard Medical School in the Division of Hematology at Brigham and Women's Hospital and Deputy Editor of the New England Journal of Medicine. He is a Master of the American College of Physicians and is a member of the American Society of Clinical Investigation and the Association of American Physicians.
He has been active in research on the treatment of malignant lymphoma including new treatments targeting CD30, CD40, HLA Class II molecules and immunoglobulin idiotype. His laboratory work has focused in part on the regulation of lymphocyte proliferation, NK cell effects on hematopoiesis, and tumor-induced immunosuppression.
Dan Longo is the Section Editor of the Malignant hematological diseases section of BMC Hematology. Read more about the key issues in this field and the manuscripts he would like to see submitted to the section in his interview with the journal.
BMC series blog
- 03 December 2013
- Highlights of the BMC-series: November 2013
- 20 November 2013
- APHA: For science. For action. For health.
- 18 November 2013
- BMC Geriatrics at the 2013 BGS Autumn Scientific Meeting
BMC Blood Disorders
BMC Hematology assimilated the Editorial board and history of BMC Blood Disorders on renaming of the journal in 2013. The full archive of BMC Blood Disorders is available here and the rationale and objectives behind the change of journal name are explained in the editorial that accompanied the relaunch.